Anna Kwilas

1.2k total citations
24 papers, 969 citations indexed

About

Anna Kwilas is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Anna Kwilas has authored 24 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Anna Kwilas's work include Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Anna Kwilas is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Anna Kwilas collaborates with scholars based in United States, India and Spain. Anna Kwilas's co-authors include James W. Hodge, Andressa Ardiani, Renee N. Donahue, Sofia R. Gameiro, Kwong Y. Tsang, Dana T. Aftab, Jeffrey Schlom, Benedetto Farsaci, Peter Kim and Emily K. Jeng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Anna Kwilas

24 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Kwilas United States	16	587	457	246	240	106	24	969
Christine Alewine United States	18	517 0.9×	395 0.9×	299 1.2×	295 1.2×	97 0.9×	51	1.1k
Aixa Soyano United States	9	713 1.2×	482 1.1×	229 0.9×	234 1.0×	110 1.0×	30	1.1k
Jason B. Muhitch United States	14	628 1.1×	649 1.4×	177 0.7×	281 1.2×	89 0.8×	33	1.2k
Jingwei Sun China	11	717 1.2×	753 1.6×	193 0.8×	438 1.8×	109 1.0×	22	1.3k
Shuhua Wei China	12	443 0.8×	559 1.2×	195 0.8×	347 1.4×	157 1.5×	21	1.1k
Nana-Ama A.S. Anang United States	4	973 1.7×	762 1.7×	162 0.7×	223 0.9×	76 0.7×	6	1.2k
Amandine Alard United States	10	851 1.4×	724 1.6×	315 1.3×	576 2.4×	169 1.6×	13	1.6k
Justin D. Saco United States	4	966 1.6×	792 1.7×	216 0.9×	368 1.5×	142 1.3×	5	1.4k
I G Schmidt-Wolf Germany	13	653 1.1×	636 1.4×	79 0.3×	190 0.8×	76 0.7×	24	1.0k
D. Ockert Germany	15	582 1.0×	345 0.8×	193 0.8×	358 1.5×	125 1.2×	47	1.2k

Countries citing papers authored by Anna Kwilas

Since Specialization

Citations

This map shows the geographic impact of Anna Kwilas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kwilas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kwilas more than expected).

Fields of papers citing papers by Anna Kwilas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kwilas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kwilas. The network helps show where Anna Kwilas may publish in the future.

Co-authorship network of co-authors of Anna Kwilas

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kwilas. A scholar is included among the top collaborators of Anna Kwilas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kwilas. Anna Kwilas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Argaw, Takele, Michael Marino, Andrew E. Timmons, et al.. (2021). In vivo targeting of lentiviral vectors pseudotyped with the Tupaia paramyxovirus H glycoprotein bearing a cell-specific ligand. Molecular Therapy — Methods & Clinical Development. 21. 670–680. 4 indexed citations

Marino, Michael, Brian J. Iaffaldano, Sandra Afione, et al.. (2020). Design and Testing of Vector-Producing HEK293T Cells Bearing a Genomic Deletion of the SV40 T Antigen Coding Region. Molecular Therapy — Methods & Clinical Development. 18. 631–638. 16 indexed citations

Hallak, Louay K., et al.. (2017). Efficient method for site-directed mutagenesis in large plasmids without subcloning. PLoS ONE. 12(6). e0177788–e0177788. 7 indexed citations

Kim, Peter, Anna Kwilas, Wenxin Xu, et al.. (2016). Abstract 3245: IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity of murine breast and colon carcinomas. Cancer Research. 76(14_Supplement). 3245–3245. 1 indexed citations

Kwilas, Anna, et al.. (2016). Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin. Oncotarget. 7(17). 23498–23511. 27 indexed citations

Kwilas, Anna, et al.. (2015). A poxviral-based cancer vaccine targeting the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model. Oncotarget. 6(29). 28194–28210. 26 indexed citations

Grenga, Italia, Anna Kwilas, Renee N. Donahue, Benedetto Farsaci, & James W. Hodge. (2015). Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack. Journal for ImmunoTherapy of Cancer. 3(1). 52–52. 18 indexed citations

Kwilas, Anna, Sofia R. Gameiro, Peter Kim, Anthony S. Malamas, & James W. Hodge. (2015). Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy. OncoImmunology. 4(6). e1009303–e1009303. 5 indexed citations

Kwilas, Anna, Renee N. Donahue, Kwong Y. Tsang, & James W. Hodge. (2015). Immune Consequences of Tyrosine Kinase Inhibitors that Synergize with Cancer Immunotherapy. PubMed. 2(1). 92 indexed citations

10.

Gabitzsch, Elizabeth S., Kwong Y. Tsang, Claudia Palena, et al.. (2015). The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic. Oncotarget. 6(31). 31344–31359. 35 indexed citations

11.

Ardiani, Andressa, Sofia R. Gameiro, Claudia Palena, et al.. (2014). Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process. Cancer Research. 74(7). 1945–1957. 29 indexed citations

12.

Gameiro, Sofia R., Andressa Ardiani, Anna Kwilas, & James W. Hodge. (2014). Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens. OncoImmunology. 3(5). e28643–e28643. 43 indexed citations

13.

Wattenberg, Max M., Anna Kwilas, Sofia R. Gameiro, Adam P. Dicker, & James W. Hodge. (2014). Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets. British Journal of Cancer. 110(6). 1472–1480. 22 indexed citations

14.

Kwilas, Anna, Andressa Ardiani, Renee N. Donahue, Dana T. Aftab, & James W. Hodge. (2014). Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine. Journal of Translational Medicine. 12(1). 294–294. 154 indexed citations

15.

Gameiro, Sofia R., Andressa Ardiani, Anna Kwilas, Renee N. Donahue, & James W. Hodge. (2014). 308 Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway. European Journal of Cancer. 50. 101–101. 2 indexed citations

16.

Kwilas, Anna, Andressa Ardiani, Renee N. Donahue, Dana T. Aftab, & James W. Hodge. (2014). Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells. Journal for ImmunoTherapy of Cancer. 2(S3). 3 indexed citations

17.

Ardiani, Andressa, Sofia R. Gameiro, Anna Kwilas, Renee N. Donahue, & James W. Hodge. (2014). Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway. Oncotarget. 5(19). 9335–9348. 66 indexed citations

18.

Hodge, James W., Anna Kwilas, Andressa Ardiani, & Sofia R. Gameiro. (2013). Attacking malignant cells that survive therapy. OncoImmunology. 2(12). e26937–e26937. 25 indexed citations

19.

Hodge, James W., Andressa Ardiani, Benedetto Farsaci, Anna Kwilas, & Sofia R. Gameiro. (2012). The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule Inhibitors. Seminars in Oncology. 39(3). 323–339. 113 indexed citations

20.

Kwilas, Anna, Liqun Zhang, Rachael M. Liesman, et al.. (2010). Respiratory Syncytial Virus Engineered To Express the Cystic Fibrosis Transmembrane Conductance Regulator Corrects the Bioelectric Phenotype of Human Cystic Fibrosis Airway Epithelium In Vitro. Journal of Virology. 84(15). 7770–7781. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact